Studies suggested that an increase of functional EGFR expression activated the JNK-ERK1/2-AP-1 axis to upregulate Cx43 expression in the TMZ-resistant GBM cells (Munoz et al., 2014). The gene discussed is GJA1; the disease is glioblastoma.